← SynDRA
BUPARLISIB
SynDRA canonical compound SYN0029034 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | PIK3CA |
| Mechanism of action | PI3K inhibitor |
All known targets
- PIK3CA
- PIK3CG
- PIK3CB
- PIK3CD
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3CA INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- PIK3CB INHIBITOR
Cross-references
Synonyms
- BKM-120
- BKM-120NX
- BKM120-NX
- NVP-BKM-120
- NVP-BKM120
- BKM120
- 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
- NVP-BKM 120
- BKM 120
- Buparlisib (BKM120)
- BKM120 (NVP-BKM120, Buparlisib)
- 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
- BKM 120NX
- 5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine
- 0ZM2Z182GD
- CHEMBL2017974
- CHEBI:71954
- 944396-07-0 (free base)
- 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine.
- Buparlisib [INN]
- Buparlisib [USAN:INN]
- UNII-0ZM2Z182GD
- 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine
- SD5
- Buparlisib; BKM120
- 3sd5
- Buparlisib (USAN/INN)
- BUPARLISIB [USAN]
- BUPARLISIB [WHO-DD]
- MLS006010984
- SCHEMBL146956
- GTPL7878
- BKM120,NVP-BKM120
- BKM-120 (PI3K)
- DTXSID50241486
- EX-A189
- HMS3295I15
- HMS3655D16
Look up BUPARLISIB in the interactive SynDRA portal →